04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
U-Haul International drew widespread commentary and some criticism for its recent announcement that ...
Read More >
Seyfarth Synopsis: Does Pennsylvania law permit the fluctuating workweek (“FWW”) method of paying ...
Read More >
In welcome news to employers, the National Labor Relations Board (NLRB) issued a decision on Decembe...
Read More >
Opioid manufacturer Insys Therapeutics, which just last week agreed to pay $225 million to “settle ...
Read More >
Hear how Hutchison PLLC provides strategic guidance to life sciences entrepreneurs to help them navi...
Read More >
Our previous Wage and Hour Watch post summarized DOL’s recent Notice of Proposed Rulemaking on the ...
Read More >